Recognized for Technological and Financial Success in Clinical Trial
Automation
WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 6, 2009--
Phase Forward (NASDAQ: PFWD), a leading provider of data management
solutions for clinical trials and drug safety, today announced the Mass
Technology Leadership Council, Inc. named Phase Forward Private Sector
Company of the Year at the 2009 Mass Technology Leadership Awards in
Boston last night. Honoring Massachusetts companies and individuals who
best exemplify leadership and excellence in business and technology, the
Technology Leadership Awards recognize outstanding achievement in both
the development and deployment of technologies.
“Phase Forward has established itself as one of Massachusetts’ premier
technology success stories,” said Tom Hopcroft, president and CEO of the
Mass Technology Leadership Council. “Under the direction of an excellent
executive team the company’s consistent drive to innovate has enabled it
to flourish. We congratulate Phase Forward on distinguishing itself in a
region whose commitment to innovation consistently produces very
successful technology companies.”
Accepting the award was Phase Forward Chairman and CEO Bob Weiler,
himself a recipient of the CEO of the year award at the 2006 Mass
Technology Leadership Awards. “I proudly accept this award on behalf of
the Phase Forward employees and customers around the world who have made
our company the success it is today,” said Weiler. “On this occasion I
would also like to acknowledge Phase Forward’s founder Paul Bleicher,
whose vision for automating clinical trials and entrepreneurial drive
set our company in motion. We are ardent supporters of the great work
MTLC does advancing technological innovation in Massachusetts, and proud
to be honored by an organization of this caliber.”
About Mass Technology Leadership Council, Inc.
Formed by the powerful combination of Mass Software Council and New
England Business and Technology Association, Inc., the organization is
dedicated to fostering entrepreneurship and promoting the success of
companies that develop and deploy technology across industry sectors.
The Mass Technology Leadership Council accomplishes its mission by
conducting educational programs and hosting signature events,
facilitating networking between industry executives and potential
partners, investors, and customers, sponsoring research on the industry,
engaging in activities to enhance the quality and quantity of the next
generation of technology professionals, advocating in favor of
technology policies that promote innovation and entrepreneurship, and
recognizing industry-leading companies and people.
About Phase Forward
Phase Forward is a leading provider of integrated data management
solutions for clinical trials and drug safety. Phase Forward’s products
and services have been utilized in over 10,000 clinical trials involving
more than 1,000,000 clinical trial study participants at over 300
organizations and regulatory agencies worldwide including: AstraZeneca,
Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S.
Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research
Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International,
Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare
Products Regulatory Agency. Additional information about Phase Forward
is available at www.phaseforward.com.
Cautionary Statement
Certain statements made in this press release that are not based on
historical information are forward-looking statements which are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. This press release contains express or
implied forward-looking statements relating to, among other things, the
performance of Phase Forward’s products and services, continued market
acceptance of Phase Forward’s products and services, and the ability of
Phase Forward’s customers to realize benefits from the use of Phase
Forward’s products and services. These statements are neither promises
nor guarantees, but are subject to a variety of risks and uncertainties,
many of which are beyond Phase Forward's control, which could cause
actual results to differ materially from those contemplated in these
forward-looking statements. In particular, the risks and uncertainties
include, among other things, the ability of Phase Forward’s customers to
realize benefits from the use of its products and services, the
possibility that customers’ needs or plans may change over time, and the
introduction or improvement of products and services competitive with
those of Phase Forward. Existing and prospective investors are cautioned
not to place undue reliance on these forward-looking statements, which
speak only as of the date hereof. Phase Forward undertakes no obligation
to update or revise the information contained in this press release,
whether as a result of new information, future events or circumstances
or otherwise. For additional disclosure regarding these and other risks
faced by Phase Forward, see the disclosure contained in Phase Forward's
public filings with the Securities and Exchange Commission including,
without limitation, its most recent Annual Report on Form 10-K.
Source: Phase Forward
Phase Forward
Elaine Maynard, 781-902-4371
elaine.maynard@phaseforward.com
or
Mass
Technology Leadership Council
Heather Johnson, 781-993-9000 x207
Heather@masstlc.org
